Attached files
| file | filename |
|---|---|
| EX-31.1 - CERTIFICATION - Lotus Biotech Development Corp. | f10q0617a2ex31-1_lotusbio.htm |
| 10-Q/A - AMENDMENT NO. 2 TO FORM 10-Q - Lotus Biotech Development Corp. | f10q0617a2_lotusbiotech.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
The undersigned executive officer of Lotus Bio-Technology Development Corp certifies pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that as of January 27, 2021
| ● | the quarterly report on Form 10-Q/A of the Company for the period ended June 30, 2017, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| ● | the information contained in the Form 10-Q/A fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: | /s/ Zoltan Nagy | |
| Zoltan Nagy | ||
| Chief Executive Officer, Chief Financial Officer, Director |